Skip to main content
Journal cover image

Human apolipoprotein E4 targeted replacement mice show increased prevalence of intracerebral hemorrhage associated with vascular amyloid deposition.

Publication ,  Journal Article
Sullivan, PM; Mace, BE; Estrada, JC; Schmechel, DE; Alberts, MJ
Published in: J Stroke Cerebrovasc Dis
September 2008

Previous studies show that APOE *4 carriers are at increased risk for ischemic stroke and intracerebral hemorrhage (ICH). The APOE *4 gene is also linked to increased incidence of cerebral amyloid angiopathy. It has been suggested that apolipoprotein E4 expression leads to increased vascular amyloid deposition, which may explain the increased incidence of ICH in APOE *4 carriers. Here we show a significant increase in ICH in apoE4 targeted replacement mice compared with apoE3 mice. In all, 89% of the vessels in the apoE4 mice that showed evidence for hemorrhage contained fibrillar amyloid beta based on thioflavine-S staining. Aged apoE4 mice contained predominantly vascular amyloid deposits in the frontal cortex and hippocampus, but also showed evidence for parenchymal amyloid deposits. Most of the parenchymal amyloid appeared diffuse in nature; however, a small fraction was thioflavine-S positive, indicating presence of fibrillar amyloid. Electron microscopy further revealed evidence for fibrillar deposits in the vessel walls of apoE4 mice, but not apoE3 mice. The apoE4 targeted replacement mice do not harbor any mutation in the amyloid precursor protein gene and, therefore, are similar to the majority of humans susceptible to cerebral amyloid angiopathy and ICH, where the APOE genetic polymorphism is the only known genetic risk factor.

Duke Scholars

Published In

J Stroke Cerebrovasc Dis

DOI

EISSN

1532-8511

Publication Date

September 2008

Volume

17

Issue

5

Start / End Page

303 / 311

Location

United States

Related Subject Headings

  • Recombinant Fusion Proteins
  • Neurology & Neurosurgery
  • Mice, Transgenic
  • Mice
  • Humans
  • Gene Targeting
  • Disease Models, Animal
  • Cerebral Hemorrhage
  • Cerebral Arteries
  • Cerebral Amyloid Angiopathy
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sullivan, P. M., Mace, B. E., Estrada, J. C., Schmechel, D. E., & Alberts, M. J. (2008). Human apolipoprotein E4 targeted replacement mice show increased prevalence of intracerebral hemorrhage associated with vascular amyloid deposition. J Stroke Cerebrovasc Dis, 17(5), 303–311. https://doi.org/10.1016/j.jstrokecerebrovasdis.2008.03.011
Sullivan, Patrick M., Brian E. Mace, Januario C. Estrada, Donald E. Schmechel, and Mark J. Alberts. “Human apolipoprotein E4 targeted replacement mice show increased prevalence of intracerebral hemorrhage associated with vascular amyloid deposition.J Stroke Cerebrovasc Dis 17, no. 5 (September 2008): 303–11. https://doi.org/10.1016/j.jstrokecerebrovasdis.2008.03.011.
Sullivan PM, Mace BE, Estrada JC, Schmechel DE, Alberts MJ. Human apolipoprotein E4 targeted replacement mice show increased prevalence of intracerebral hemorrhage associated with vascular amyloid deposition. J Stroke Cerebrovasc Dis. 2008 Sep;17(5):303–11.
Sullivan, Patrick M., et al. “Human apolipoprotein E4 targeted replacement mice show increased prevalence of intracerebral hemorrhage associated with vascular amyloid deposition.J Stroke Cerebrovasc Dis, vol. 17, no. 5, Sept. 2008, pp. 303–11. Pubmed, doi:10.1016/j.jstrokecerebrovasdis.2008.03.011.
Sullivan PM, Mace BE, Estrada JC, Schmechel DE, Alberts MJ. Human apolipoprotein E4 targeted replacement mice show increased prevalence of intracerebral hemorrhage associated with vascular amyloid deposition. J Stroke Cerebrovasc Dis. 2008 Sep;17(5):303–311.
Journal cover image

Published In

J Stroke Cerebrovasc Dis

DOI

EISSN

1532-8511

Publication Date

September 2008

Volume

17

Issue

5

Start / End Page

303 / 311

Location

United States

Related Subject Headings

  • Recombinant Fusion Proteins
  • Neurology & Neurosurgery
  • Mice, Transgenic
  • Mice
  • Humans
  • Gene Targeting
  • Disease Models, Animal
  • Cerebral Hemorrhage
  • Cerebral Arteries
  • Cerebral Amyloid Angiopathy